0 Комментарии
0 Поделились
2Кб Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Новости
- ИССЛЕДОВАТЬ
-
Страницы
-
Группы
-
Мероприятия
-
Статьи пользователей
-
Marketplace
-
Форумы
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Are Personalized Cancer Vaccines the Future of Oncology Treatment?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The market...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
How Are Oncology Treatment Innovations Boosting the Europe Tumor Ablation Market?Global Executive Summary Europe Tumor Ablation Market: Size, Share, and Forecast CAGR Value The Europe tumor ablation market size was valued at USD 584.50 million in 2025 and is expected to reach USD 1,349.91 million by 2033, at a CAGR of 11.03% during the forecast period The Europe Tumor Ablation Market analysis report focuses on leading global industry players, providing information such...0 Комментарии 0 Поделились 834 Просмотры 0 предпросмотр
-
Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Radiation Oncology Treatment Planning Software Market Advances with AI Integration"In-Depth Study on Executive Summary Radiation Oncology Treatment Planning Software Market Size and Share CAGR Value Data Bridge Market Research analyses that the radiation oncology treatment planning software market which was USD 2.18 billion in 2022, would rocket up to USD 4.34 billion by 2030, and is expected to undergo a CAGR of 9.00% during the forecast period 2023 to 2030...0 Комментарии 0 Поделились 430 Просмотры 0 предпросмотр
-
Urothelial Carcinoma Treatment Market Expands with Advancements in Oncology Therapies"Executive Summary Urothelial Carcinoma Treatment Market: Growth Trends and Share Breakdown CAGR Value Data Bridge Market Research analyses a growth rate in the global urothelial carcinoma treatment market in the forecast period 2023-2030. The expected CAGR of global urothelial carcinoma treatment market is tend to be around 20% in the mentioned forecast period In this competitive...0 Комментарии 0 Поделились 370 Просмотры 0 предпросмотр
-
Why the Subcutaneous Oncology Biologic Drug Market Is Transforming Cancer Treatment Delivery"Market Trends Shaping Executive Summary Subcutaneous Oncology Biologic Drug Market Market Size and Share CAGR Value The global Subcutaneous Oncology Biologic Drug market size was valued at USD 15.78 billion in 2025 and is expected to reach USD 34.82 billion by 2033, at a CAGR of 10.40% during the forecast period A comprehensive analysis of the market...0 Комментарии 0 Поделились 742 Просмотры 0 предпросмотр
-
Are Immune-Modulating Biologics Redefining the Future of Cancer Immunotherapy?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Size and Share: Global Industry Snapshot CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period The research and analysis...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
Are Neoantigen Cancer Vaccines the Next Breakthrough in Personalized Oncology?Executive Summary Neoantigen Cancer Vaccine Therapy Market Market Size and Share Forecast CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The comprehensive market information and data of...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Are Personalized Cancer Vaccines Transforming the Future of Oncology?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value The market insights gained through this keyword market research analysis report facilitate a more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position a definite brand excellently. With the scrupulous competitor analysis covered in...0 Комментарии 0 Поделились 485 Просмотры 0 предпросмотр
-
Are Surgical Innovations Improving Outcomes in Lung Cancer Treatment?Lung Cancer Surgery Market Summary: According to the latest report published by Data Bridge Market Research, the Lung Cancer Surgery Market CAGR Value This global Lung Cancer Surgery Market report is a wonderful guide to achieve an information or key data about market, emerging trends, product usage, motivating factors for customers, competitor strategies, brand...0 Комментарии 0 Поделились 174 Просмотры 0 предпросмотр
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Комментарии 0 Поделились 2Кб Просмотры 0 предпросмотр
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Комментарии 0 Поделились 643 Просмотры 0 предпросмотр
-
Can RNA-Based Therapeutics Revolutionize Cancer Treatment?RNA-Based Cancer Therapeutics Market Summary: According to the latest report published by Data Bridge Market Research, the RNA-Based Cancer Therapeutics Market CAGR Value For structuring the finest market research report like this RNA-Based Cancer Therapeutics Market, a devoted team of experienced forecasters, well-versed analysts and knowledgeable researchers work...0 Комментарии 0 Поделились 36 Просмотры 0 предпросмотр
-
Can Targeting Endocrine Resistance Unlock New Breakthroughs in Cancer Treatment?Executive Summary Endocrine Resistance–Targeting Drug Market Size and Share Analysis Report CAGR Value The global endocrine resistance–targeting drug market size was valued at USD 2.96 billion in 2025 and is expected to reach USD 8.50 billion by 2033, at a CAGR of 14.10% during the forecast period This Endocrine...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
-
CAR-T Cell Therapy Market Demand Rising Across Global HealthcareExpanding healthcare infrastructure in emerging economies is creating new opportunities for the CAR-T cell therapy market. Countries in Asia-Pacific and Latin America are investing in advanced cancer treatment facilities. This expansion supports global market growth. CAR-T Cell Therapy Market to Reach US$ 10.13 Billion by 2030 with 17.5% CAGR The global CAR-T Cell Therapy Market is witnessing...0 Комментарии 0 Поделились 3Кб Просмотры 0 предпросмотр
-
Checkpoint Inhibitor Refractory Cancer Market to Reach USD 8.75 Billion by 2032 | CAGR 9.6%According to a newly published market research report by 24LifeSciences, global checkpoint inhibitor refractory cancer market was valued at USD 4.2 billion in 2024 and is projected to reach USD 8.75 billion by 2032, growing at a compound annual growth rate (CAGR) of 9.6% during the forecast period 2025–2032. Checkpoint inhibitor refractory cancer occurs when tumors develop...0 Комментарии 0 Поделились 1Кб Просмотры 0 предпросмотр
Расширенные страницы
Спонсоры
Спонсоры
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek